Biocryst Pharmaceuticals (BCRX) Return on Assets (2011 - 2026)

Biocryst Pharmaceuticals' Return on Assets history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Assets fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Biocryst Pharmaceuticals, down from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q4 2025 and bottomed at 0.01% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2025 — Return on Assets grew 1 bps — and 2026, when it fell 1 bps.
• Biocryst Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then advanced by 2 bps to 0.0% in 2023, then jumped by 58 bps to 0.0% in 2024, then surged by 403 bps to 0.01% in 2025, then tumbled by 270 bps to 0.01% in 2026.
• Business Quant data shows BCRX's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.